MedicalExpo Interviews Singclean Medical at Medical Fair Asia 2026

Highlighting Innovation and Global Partnership

Singapore, September 10, 2026 — During Medical Fair Asia 2026 in Singapore, Singclean Medical was honored to be interviewed by MedicalExpo, an authoritative international vertical platform serving the global medical device industry. The interview provided an opportunity for Singclean to showcase its innovative hemostasis solution, share its international development strategy, and highlight the value of long-term cooperation with MedicalExpo in strengthening its global presence.

Established in 2003, Singclean Medical has been committed to becoming a leading player in the field of absorbable biomaterials. Today, the company has developed key product portfolios covering Aesthetics, Medical Devices, Hemostasis, IVD, and Skincare, with products and solutions introduced across more than 80 countries and regions. During the interview, Lydia Liu, Asian-Pacific Regional Director of Singclean Medical, introduced the company's featured product at the exhibition — Surgiclean MPH Absorbable Hemostatic Particles.

As an absorbable hemostat designed for surgical procedures, Surgiclean MPH is applied to surgical wound sites to help control bleeding from capillaries, veins, and small arteries when conventional methods such as ligation or pressure are ineffective. The product is designed specifically for use by doctors during surgical procedures, addressing the need for effective hemostatic management across a range of surgical situations.

A key highlight discussed during the interview was the product's plant-based technology. According to Singclean, Surgiclean MPH is China's first domestically produced absorbable hemostat with pure plant-source certification and is made entirely from potato starch. Singclean's proprietary cultivation and traceability system enables control from seed to finished product. Its emulsification and cross-linking technology creates a highly porous molecular-sieve structure with a large surface area, enabling rapid fluid absorption and conformity to irregular wound surfaces.

The interview also highlighted Surgiclean's dual-action hemostatic mechanism. By rapidly absorbing water from blood, the hydrophilic molecular-sieve structure concentrates formed elements to create a gel-like matrix that mechanically seals the bleeding site. At the same time, it locally concentrates platelets, coagulation factors, and fibrin to support the intrinsic coagulation pathway, contributing to rapid and sustained hemostasis. The product is plant-derived and designed to completely degrade in the body within 14 days.

With CE, TGA, ANVISA, and MHRA certifications, Surgiclean has gained market recognition in more than 30 countries. From 2021 to 2025, more than 1.6 million units had been used by surgeons worldwide, providing practical market experience and supporting Singclean's continued international expansion.

Beyond product innovation, the interview underscored the importance of international partnerships. Singclean is seeking experienced distributors in the hemostasis and operating-room sectors, particularly partners with established product portfolios, strong channel knowledge, and clinical credibility.

Singclean also shared its positive experience with MedicalExpo as part of its international marketing strategy. As a specialized medical industry platform, MedicalExpo has helped increase Singclean's product visibility, support Google search performance and domain authority, and strengthen customer trust in the brand. Singclean highly recommends MedicalExpo to medical device manufacturers seeking to expand their global presence.

The interview at Medical Fair Asia 2026 represents more than a product showcase. It reflects the growing value of cooperation between innovative medical device manufacturers and specialized global industry platforms. Through continued collaboration, Singclean Medical and MedicalExpo can help connect innovative medical solutions with qualified international professionals, distributors, and B2B buyers, creating greater opportunities for global market development and industry exchange.

Singclean Medical looks forward to continuing its collaboration with MedicalExpo and other international partners to bring innovative medical solutions to more markets and contribute to the advancement of global healthcare.